Yubo Intl Biotech A (YBGJ) Total Assets by Year
Yubo Intl Biotech Ltd A closed fiscal year 2025 with $847K in total assets, $2.8M in total liabilities and -$2.0M in shareholder equity. Total assets fell 44.8% from the prior fiscal year. The table below carries 15 fiscal years, from 2012 to 2025, and the quarters Yubo Intl Biotech Ltd A has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
YBGJ Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $847K-44.8% | $1.5M-7.9% | $1.7M-29.0% | $2.3M-48.8% | $4.6M+87.6% | $2.4M | $1K-75.0% | $4K | N/A | N/A | $14K | N/A | N/A | N/A | N/A |
| Total Liabilities | $2.8M-42.2% | $4.8M+37.6% | $3.5M+20.5% | $2.9M-38.2% | $4.7M+269.4% | $1.3M | -$827K-149.6% | $1.7M | N/A | N/A | $1.3M | N/A | N/A | N/A | N/A |
| Total Equity | -$2.0Mn/m | -$3.4Mn/m | -$1.8Mn/m | -$565Kn/m | -$131K-111.2% | $1.2M | $828Kn/m | -$1.7Mn/m | -$1.5Mn/m | -$1.4Mn/m | -$1.3Mn/m | -$1.1Mn/m | -$1.0Mn/m | -$906Kn/m | -$803K |
YBGJ Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $672K-36.1% | $710K-39.1% | $847K-44.8% | $953K-42.4% | $1.1M-39.2% | $1.2M-24.7% | $1.5M-7.9% | $1.7M-13.1% | $1.7M-11.9% | $1.5M-26.7% | $1.7M-29.0% | $1.9M-48.8% |
| Total Liabilities | $3.3M-33.9% | $3.0M-37.3% | $2.8M-42.2% | $2.6M-45.6% | $5.0M+21.3% | $4.8M+33.3% | $4.8M+37.6% | $4.7M+56.3% | $4.1M+33.3% | $3.6M+22.3% | $3.5M+20.5% | $3.0M-31.4% |
| Total Equity | -$2.6Mn/m | -$2.3Mn/m | -$2.0Mn/m | -$1.7Mn/m | -$4.0Mn/m | -$3.7Mn/m | -$3.4Mn/m | -$3.1Mn/m | -$2.5Mn/m | -$2.1Mn/m | -$1.8Mn/m | -$1.1Mn/m |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Yubo Intl Biotech Ltd A financials
Frequently Asked Questions
Yubo Intl Biotech Ltd A closed fiscal year 2025 with $847K in total assets, $2.8M in total liabilities and -$2.0M in shareholder equity.
Yubo Intl Biotech Ltd A (YBGJ) total assets fell by 44.8% year over year, from $1.5M to $847K in fiscal year 2025.
Yubo Intl Biotech Ltd A (YBGJ) reported $672K in total assets in Q2 2026. This represents a decrease of 36.1% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Yubo Intl Biotech Ltd A (YBGJ) reported on that line in every period on record.